Abstract |
|
Authors | Judith E Karp, Francis J Giles, Ivana Gojo, Lawrence Morris, Jacqueline Greer, Bonny Johnson, Mya Thein, Mario Sznol, Jennifer Low |
Journal | Leukemia research
(Leuk Res)
Vol. 32
Issue 1
Pg. 71-7
(Jan 2008)
ISSN: 0145-2126 [Print] England |
PMID | 17640728
(Publication Type: Clinical Trial, Phase I, Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Pyridines
- Thiosemicarbazones
- 3-aminopyridine-2-carboxaldehyde thiosemicarbazone
- Vidarabine
- fludarabine
|
Topics |
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Female
- Humans
- Leukemia, Myeloid, Acute
(drug therapy)
- Male
- Middle Aged
- Myelodysplastic Syndromes
(drug therapy)
- Myeloproliferative Disorders
(drug therapy)
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
(diet therapy)
- Pyridines
(administration & dosage)
- Recurrence
- Thiosemicarbazones
(administration & dosage)
- Treatment Outcome
- Vidarabine
(administration & dosage, analogs & derivatives)
|